Spore.Bio

Spore.Bio develops technology for rapid microbiology testing that uses light-based sensing and AI to detect and quantify microbial contamination in products across industries like food, beverages, cosmetics, pharmaceuticals, and water systems. The company’s platform combines machine learning models with photonic data to produce near-real-time insights about bacterial presence without the long incubation times required by traditional lab methods. Spore.Bio also integrates testing hardware with analytical dashboards that help quality teams monitor contamination trends and process data. The firm collaborates with scientific partners to expand its microbial datasets and continuously refine detection models. Its offerings aim to support manufacturers in transitioning from delayed lab testing toward faster contamination awareness and response.

Domain

spore.bio

Country

France

Employees

101-250

Founded

2022

Frequently Asked Questions

What technologies does Spore.Bio use?+

Spore.Bio uses 12 technologies including Google Font API, Webflow, GSAP.

What industry is Spore.Bio in?+

Spore.Bio operates in the Artificial Intelligence (AI) industry.

Where is Spore.Bio based?+

Spore.Bio is headquartered in France.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026